| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Allurion Technologies (NYSE:ALUR) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of...
Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a pioneer in metabolically healthy weig...
Multicenter study across six countries demonstrates safety and efficacy of two consecutive treatments in adults with obesityWei...